Autoantibodies against oxidated low density lipoproteins (oLAb) and procalcitonin (PCT) as prognostic markers for patients suffering from sepsis and systemic inflammatory response syndrome (SIRS)

Documenti analoghi

• Procalcitonin (PCT) for monitoring ICU patients with severe polytrauma and early SIRS: results of a prospective study
  di: Stiletto, RJ, et al.
  Pubblicazione: (1998)
• Procalcitonin (PCT)
  di: Horns, Heidi, et al.
  Pubblicazione: (2021)
• Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
  di: Brunkhorst, FM, et al.
  Pubblicazione: (1999)
• Guiding Effect of Serum Procalcitonin (PCT) on the Antibiotic Application to Patients with Sepsis
  di: LIU, Yu, et al.
  Pubblicazione: (2017)
• A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
  di: Çelebi, S, et al.
  Pubblicazione: (2000)